Compound Detail
CHEMBL489
AFIMOXIFENE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL489 |
| Name | AFIMOXIFENE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | TXUZVZSFRXZGTL-QPLCGJKRSA-N |
12
Targets
77
Activities
3
Assay Types
7
PK Parameters
20
Publications
5
Known Names
3
Indications
2
Mechanisms
Molecular Properties
387.5
MW (Da)
5.70
ALogP
3
HBA
1
HBD
32.7
PSA (Ų)
0.50
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Estrogen receptor modulator | MODULATOR | Estrogen receptor | ✓ | ✓ |
| Estrogen-related receptor gamma antagonist | ANTAGONIST | Estrogen-related receptor gamma | ✓ | ✓ |
Indications
Breast Neoplasms Carcinoma, Intraductal, Noninfiltrating Mastodynia
Activity Summary
IC50 67 meas. best 9.28
EC50 8 meas. best 10.01
Ki 2 meas. best 7.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Estrogen receptor CHEMBL206 | EC50 | 10.01 | 10.01 | 0.1 | 1 |
| Estrogen receptor CHEMBL206 | IC50 | 9.28 | 8.4736 | 0.5 | 14 |
| Estrogen receptor beta CHEMBL242 | IC50 | 9.0 | 8.74 | 1.0 | 3 |
| MCF7 CHEMBL387 | IC50 | 8.92 | 5.9642 | 1.2 | 19 |
| Ishikawa CHEMBL614649 | IC50 | 8.9 | 8.9 | 1.3 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.47 | 6.585 | 3.4 | 2 |
| MCF7 CHEMBL387 | EC50 | 8.46 | 6.2167 | 3.5 | 3 |
| Estrogen receptor CHEMBL206 | Ki | 7.7 | 7.7 | 20.0 | 1 |
| T47D CHEMBL614361 | IC50 | 7.62 | 5.6675 | 24.0 | 8 |
| MDA-MB-231 CHEMBL400 | IC50 | 7.43 | 5.4125 | 36.8 | 4 |
| Estrogen receptor beta CHEMBL242 | Ki | 7.16 | 7.16 | 70.0 | 1 |
| MDA-MB-231 CHEMBL400 | EC50 | 5.11 | 5.105 | 7800.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 5.06 | 4.7157 | 8758.0 | 7 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Ishikawa CHEMBL614649 | EC50 | 4.94 | 4.94 | 11500.0 | 1 |
| Vero CHEMBL391 | IC50 | 4.82 | 4.82 | 15100.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 4.82 | 4.82 | 15300.0 | 1 |
| MCF-10A CHEMBL614321 | IC50 | 4.68 | 4.672 | 21000.0 | 5 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 14.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 32.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | - | - | Rattus norvegicus |
| F | 87.0 | % | Rattus norvegicus |
| F | 94.0 | % | Rattus norvegicus |
| Ka | 0.25 | nM | Homo sapiens |
| Ka | 2.03 | nM | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | U2OS | 320 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 320 |
| - | 10.6019/CHEMBL5724801 | Fibroblast | 320 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
| 34710747 | 10.1016/j.ejmech.2021.113869 | Estrogen receptor | 8 |
| 34710747 | 10.1016/j.ejmech.2021.113869 | MCF7 | 8 |
| 34710747 | 10.1016/j.ejmech.2021.113869 | ADMET | 6 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 6 |
| 30940565 | 10.1016/j.bmc.2019.03.042 | Estrogen receptor | 6 |
| 34710747 | 10.1016/j.ejmech.2021.113869 | Breast carcinoma cell | 6 |
| 33904307 | 10.1021/acs.jmedchem.0c02230 | Estrogen receptor | 5 |
| 34251202 | 10.1021/acs.jmedchem.1c00847 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 38809993 | 10.1021/acs.jmedchem.4c00196 | MCF7 | 4 |
| 37161783 | 10.1021/acs.jmedchem.2c02032 | Unchecked | 3 |
| 34251202 | 10.1021/acs.jmedchem.1c00847 | Estrogen receptor | 3 |
| 34251202 | 10.1021/acs.jmedchem.1c00847 | ADMET | 3 |
| 37037140 | 10.1016/j.ejmech.2023.115328 | Estrogen receptor | 3 |
| 25198997 | 10.1021/jm500873e | NON-PROTEIN TARGET | 3 |
| 31746603 | 10.1021/acs.jmedchem.9b01580 | T47D | 3 |
Data from ChEMBL 36 via Core Engine